Contribution seq 14174

CREATE_SOURCE_LOCATION EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-28T23:35:02.178370Z · client time 2026-09-28T23:35:02Z

client signature: verifies server signature: verifies chain: intact

prev sha256:aeedf4d445ff16a3453833062836da43e9c6f2612e7572d88e7b33fe5e5c424e
entry sha256:101a8714dfcf368854fe3eeb76ecd61b0973f97960f54625e323f8f3caedb09e
envelope sha256:9a9d25fc40cff8b369bca25f219a6c486e6b2a1809370cd78a92d15ee5e8ee17
payload sha256:f5c7fc9a04ceba328e4f87a7d46ba18213f17f4446265416522216aa16e4f807

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "excerpt": "When combined with carbohydrate antigen 19-9 levels, this blood assay demonstrated a sensitivity of 86.8% for stage I–II PDAC, false-positive rates of 3.2% in low-risk controls and 15.6% in high-risk controls in the testing cohort.",
  "locator": {},
  "source_id": "d5489cad-3b72-89f9-9df8-90319b05960c",
  "excerpt_hash": "sha256:6356a3a1762f407e48526e7db9e58e7fa58a345cbdde84b8a3d0affab4af24af",
  "locator_type": "QUOTE"
}

Rows created

SourceLocation b2e2a51c-6724-81b5-94a8-4561481c9582

Status history

seq	event	detail
14174	APPENDED
14175	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}